{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:39:13Z","timestamp":1758040753376,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.amjmed.2008.06.028","type":"journal-article","created":{"date-parts":[[2008,10,26]],"date-time":"2008-10-26T04:07:59Z","timestamp":1224994079000},"page":"e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cephalexin Remains Preferred Oral Antibiotic Therapy for Uncomplicated Cellulitis"],"prefix":"10.1016","volume":"121","author":[{"given":"Burke A.","family":"Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2008.06.028_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.amjmed.2008.01.028","article-title":"Efficacy of oral \u03b2-lactam treatment of uncomplicated cellulitis","volume":"121","author":"Madaras-Kelly","year":"2008","journal-title":"Am J Med"},{"year":"2008","series-title":"Antibiotic Essentials","author":"Cunha","key":"10.1016\/j.amjmed.2008.06.028_bib2"},{"key":"10.1016\/j.amjmed.2008.06.028_bib3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.1989.03430100063024","article-title":"Group A streptococcal resistance to clindamycin and erythromycin","volume":"262","author":"Sorbello","year":"1989","journal-title":"JAMA"},{"year":"1997","series-title":"The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs","key":"10.1016\/j.amjmed.2008.06.028_bib4"},{"key":"10.1016\/j.amjmed.2008.06.028_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-89-5-650","article-title":"Cefazolin","volume":"89","author":"Quintiliani","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjmed.2008.06.028_bib6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0025-7125(16)32589-5","article-title":"Cephalexin","volume":"54","author":"Griffith","year":"1970","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.amjmed.2008.06.028_bib7","first-page":"185","article-title":"Pharmacokinetics of high dose oral Cephalosporins","volume":"19","author":"Chow","year":"1979","journal-title":"J Pharmacol"},{"key":"10.1016\/j.amjmed.2008.06.028_bib8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.mcna.2006.07.009","article-title":"Oral antibiotic therapy of serious systemic infections","volume":"90","author":"Cunha","year":"2006","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.amjmed.2008.06.028_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1358\/dot.2001.37.5.627953","article-title":"Intravenous to oral antibiotic switch therapy","volume":"37","author":"Cunha","year":"2001","journal-title":"Drugs Today (Barcelona)"},{"key":"10.1016\/j.amjmed.2008.06.028_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhin.2007.12.001","article-title":"Simplified clinical approach to community acquired MRSA (CA MRSA) infections","volume":"68","author":"Cunha","year":"2008","journal-title":"J Hosp Infect"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308006797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934308006797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:49:23Z","timestamp":1757580563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934308006797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0002934308006797"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.06.028","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cephalexin Remains Preferred Oral Antibiotic Therapy for Uncomplicated Cellulitis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2008.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}